T&L Co. Ltd - Asset Resilience Ratio
T&L Co. Ltd (340570) has an Asset Resilience Ratio of 33.68% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check T&L Co. Ltd (340570) strategic asset index to assess the company's strategic physical and investment asset allocation.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2024)
This chart shows how T&L Co. Ltd's Asset Resilience Ratio has changed over time. See 340570 net asset quality index to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down T&L Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of T&L Co. Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩73.82 Billion | 33.68% |
| Total Liquid Assets | ₩73.82 Billion | 33.68% |
Asset Resilience Insights
- Very High Liquidity: T&L Co. Ltd maintains exceptional liquid asset reserves at 33.68% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
T&L Co. Ltd Industry Peers by Asset Resilience Ratio
Compare T&L Co. Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Jafron Biomedical Co Ltd
SHE:300529 |
Medical Devices | 39.15% |
|
HOB Biotech Group Corp Ltd
SHG:688656 |
Medical Devices | 2.62% |
|
Polynovo Ltd
AU:PNV |
Medical Devices | 0.04% |
|
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317 |
Medical Devices | 10.88% |
|
Dirui Industrial Co Ltd
SHE:300396 |
Medical Devices | 6.89% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
Annual Asset Resilience Ratio for T&L Co. Ltd (2017–2024)
The table below shows the annual Asset Resilience Ratio data for T&L Co. Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 38.11% | ₩75.10 Billion ≈ $50.89 Million |
₩197.08 Billion ≈ $133.56 Million |
+4.84pp |
| 2023-12-31 | 33.27% | ₩47.27 Billion ≈ $32.04 Million |
₩142.11 Billion ≈ $96.30 Million |
+6.23pp |
| 2022-12-31 | 27.04% | ₩31.64 Billion ≈ $21.44 Million |
₩117.00 Billion ≈ $79.29 Million |
-10.21pp |
| 2021-12-31 | 37.25% | ₩36.62 Billion ≈ $24.82 Million |
₩98.31 Billion ≈ $66.62 Million |
-6.33pp |
| 2020-12-31 | 43.59% | ₩34.63 Billion ≈ $23.47 Million |
₩79.45 Billion ≈ $53.84 Million |
+32.30pp |
| 2019-12-31 | 11.29% | ₩4.89 Billion ≈ $3.31 Million |
₩43.32 Billion ≈ $29.36 Million |
+3.73pp |
| 2018-12-31 | 7.56% | ₩2.76 Billion ≈ $1.87 Million |
₩36.53 Billion ≈ $24.76 Million |
+1.75pp |
| 2017-12-31 | 5.82% | ₩1.95 Billion ≈ $1.32 Million |
₩33.57 Billion ≈ $22.75 Million |
-- |
About T&L Co. Ltd
T&L Co., Ltd. engages in the manufacture and sale of medical and polymer material products in South Korea. Its chemical products include water borne resins, hardeners, functional additives, and urethane foam; wound care products, including hydrocolloid, foam, hydrogel, silicone, alginate, and other products; and orthopedic products, such as cast, splint, and other products. T&L Co., Ltd. was foun… Read more